Taken together, the above findings indicate that elevated PLAU expression has a stronger association with immunosuppressive TME signatures (PD-L1 and PD-L2) than with the anti-tumour immune signature (CD8+ T cells) in the TCGA-PDAC cohort. The gene discussed is PLAU; the disease is neoplasm.